CytomX’s Collaboration and Licensing Agreement With Regeneron Pharmaceuticals

Latham & Watkins LLP represented CytomX in the transaction.Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and CytomX Therapeutics, Inc. (NASDAQ: CTMX) have announced a collaboration and licensing agreement…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now